Medical Ventures
Recent activities involving Medical Ventures announced
Published in MD Week, May 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Medical Ventures.
Report 1: MEDICAL VENTURES CORP. (TSXV: MEV), a medical devices company specializing in products for the vascular and surgical markets, has received physician feedback from its Metricath Gemini(R) dual-balloon angioplasty device clinical trial.
Physicians participating in the GAAME (Gemini Angioplasty and Arterial Measurement Evaluation) trial responded to a questionnaire administered for each patient as part of the human trial assessing safety and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
Source: MD Week (2007-05-25)
More Articles from MD Week
- Anatomy
Studies from University of Bristol, Department of Anatomy add new findings in the area of anatomy - Arthritis Risk Factors
New findings from Johns Hopkins Bayview Medical Center, Division of Rheumatology describe advances in arthritis risk factors - Cancer Vaccines
Stanford researchers identify immune dysfunction in melanoma patients - Depression
CMS Issues Decision for Vns Therapy In Treatment-resistant Depression - Diphtheria
GlaxoSmithKline's investigational DTaP-IPV combination vaccine shown to be immunogenic and well-tolerated in Phase III clinical trial - Gender Studies
University of Wolverhampton reports research in gender studies - More from this issue of MD Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
